18F-PM-PBB3 ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 13 | 多発性硬化症／視神経脊髄炎 | 1 |
13. 多発性硬化症／視神経脊髄炎
臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04242056 (ClinicalTrials.gov) | February 20, 2020 | 21/1/2020 | To Study the Pathophysiological Features of Multiple Sclerosis | To Study the Pathophysiological Features of Multiple Sclerosis: Combined Multi-modalities of Amyloid and Tau Images Associated With Serum Neurofilament Light Chain Levels | Multiple Sclerosis;Neurofilament Light Chain;Glial Fibrillary Acidic Protein | Drug: 18F-PM-PBB3 | Chang Gung Memorial Hospital | NULL | Not yet recruiting | 20 Years | 70 Years | All | 38 | Phase 1/Phase 2 | NULL |